Epiomic Epidemiology Series: Angina Pectoris Forecast in 8 Major Markets 2015-2025

Date: 2015-09

Epidemiology Series Forecast Report on Angina Pectoris in 8 Major Markets Angina Pectoris is the term given to the pain or discomfort felt when the heart muscle lacks an adequate supply of oxygen rich blood (ischaemia). The main cause of angina is coronary arterial disease (CAD), which is the obstruction of coronary arteries due to build up of atherosclerotic plaque. Other forms of angina include microvascular angina (MVD) also known as Cardiac Syndrome X. This report provides the current prevalent population for Angina Pectoris across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of course of progression, coronary vessels affected and associated co-morbidities of Angina Pectoris. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Angina Pectoris have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Angina Pectoris include:
• Diabetes
• Hypertension
• Dyslipidemia
• Chronic heart failure
• Peripheral artery disease
• Erectile dysfunction
• Aortic valve sclerosis
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Angina Pectoris’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the prevalence of the subdivided types of Angina Pectoris and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on Angina Pectoris’s prevalent population.
• Identify sub-populations within Angina Pectoris which require treatment.
• Gain an understanding of the specific markets that have the largest number of Angina Pectoris patients.


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample